3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Neoplasms
3
Stomatitis
2
Recurrence
2
Nasopharyngeal Carcinoma
2
Meningeal Carcinomatosis
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Anemia
2
Vitamin B 12 Deficiency
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thrombocytopenia
1
Stroke
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neutropenia
1
Neuralgia
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Myocardial Infarction
1
Mesothelioma
1
Head and Neck Neoplasms
1
HR-positive Breast Cancer
1
Gliosarcoma
1
Interventions
Pemetrexed
22
Cisplatin
20
Nivolumab
8
Gemcitabine
7
Carboplatin
7
durvalumab
5
Ipilimumab
5
Bevacizumab
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
tremelimumab
3
niraparib
3
Oxaliplatin
3
Drug Therapy
3
Cyclophosphamide
3
Cerebral Decortication
3
Blood Specimen Collection
3
sargramostim
2
Thoracoscopy
2
Surveys and Questionnaires
2
Sorafenib
2
Radiosurgery
2
Magnesium Sulfate
2
Leucovorin
2
Imatinib Mesylate
2
Hyperthermic Intraperitoneal Chemotherapy
2
Doxorubicin
2
Dexamethasone
2
tislelizumab
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mesothelioma
×
Vitamin B 12
×
Clear all
NCT01569919
2013-03-12
SKOPOS
Wales Cancer Trials Unit
Phase 2
Unknown
26 enrolled